ADVIN
Dead / Abandoned — Abandoned — after publication (as of 11 Feb 2026)
What this means for you
This application is over — abandoned 10 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98708994
- Mark type
- Design + words
- Filed
- 21 Aug 2024
- Published for opposition
- 03 Jun 2025
- Abandoned
- 10 Feb 2026
- Attorney of record
- Yaling Zhou
Goods and services
- Class 010 — Medical apparatus: Blood testing apparatus; Cases fitted for medical instruments; Hematology analyzers for medical diagnostic uses; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for substance abuse drug testing and testing infectious diseases, cardiovascular disease, cerebrovascular disease, fertility, tumors and DNA, using testing methods, namely, colloidal gold readout, and modern photoelectric technology; Medical diagnostic instruments for the analysis of body fluids; Medical instruments for analysing and identifying bacteria
Owner
- Hangzhou Biotest Biotech Co., Ltd., Hangzhou, Zhejiang, CN
- Hangzhou Biotest Biotech Co., Ltd., Hangzhou, Zhejiang, CN
Prosecution history
- 11 Feb 2026 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 11 Feb 2026 — ABANDONMENT - AFTER PUBLICATION
- 10 Feb 2026 — TEAS EXPRESS ABANDONMENT RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Mar 2025 — NON-FINAL ACTION E-MAILED
- 05 Mar 2025 — NON-FINAL ACTION WRITTEN
- 05 Mar 2025 — ASSIGNED TO EXAMINER